Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Neurodegenerative Disorder Therapeutics Market for 2024-2033?
In recent times, there has been robust growth in the market size for therapeutics of neurodegenerative disorders. The size is projected to increase from $18.53 billion in 2023 to $20.04 billion in 2024, indicating a compound annual growth rate (CAGR) of 8.1%. The historical growth in this market has been driven by factors such as an aging population, increasing cases of neurodegenerative disorders, enhanced life expectancy, heightened investments by pharmaceutical companies, and greater awareness and advocacy.
In the coming years, the neurodegenerative disorder therapeutics market is anticipated to experience robust growth. By 2028, it’s predicted to reach a value of $28.33 billion, growing at a compound annual growth rate (CAGR) of 9.0%. The surge in the predicted period is due to factors such as increased demand for personalized and targeted therapy, higher availability of clinical trials, and increased healthcare spendings. Upcoming trends within the predicted period encompass disease-modifying therapies, non-drug interventions, telemedicine and remote patient monitoring, technological advancements, precision therapeutics, digital health solutions, and biomarker-based trials.
Claim Your Free Sample of the Global Neurodegenerative Disorder Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp
What Drivers Are Enhancing the neurodegenerative disorder therapeutics Market’s Growth?
The escalating incidence of neurodegenerative disorders globally is playing a major role in the expansion of the neurodegenerative disorder therapeutics market. The surge in the elderly population is identified as a key factor behind the increased occurrence of neurodegenerative diseases. As per the World Population Prospects, there is a speculation that the count of individuals aged 60 and above is estimated to reach 2.1 billion by 2050. Moreover, the population of those above 80 is anticipated to triple to 425 million in 2050. The Alzheimer’s Association reveals that approximately 5.8 million Americans are afflicted with Alzheimer’s disease, with predictions indicating a rise to roughly 14 million by 2050. The growing incidence of neurodegenerative diseases among older people heightens the requirement for neurodegenerative disorder therapeutics, thereby propelling the growth of the neurodegenerative disorder therapeutics market.
What Segments Are Central to the Neurodegenerative Disorder Therapeutics Market?
1) By Indication Type: Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
What Emerging Trends Are Influencing Neurodegenerative Disorder Therapeutics Industry Dynamics?
Various strategic alliances with both governmental and non-governmental entities are being formed by manufacturers in the neurodegenerative disorder therapeutics industry in order to invent and enhance treatments for a variety of neurodegenerative diseases. These companies are also amplifying their partnerships with other key players in the sector to bolster their research and development capabilities for creating new and more efficacious therapeutic interventions for neurodegenerative disorders. For example, in July 2022, NRG Therapeutics, a British company specialising in therapeutic strategies, teamed up with Domainex, another UK-based drug discovery service, seeking to create treatments for neurodegenerative conditions. The collaboration aims at developing innovative small molecule disease-modifying drugs for the treatment of chronic debilitating neurodegenerative diseases such as Parkinson’s and motor neurone disease (MND).
Order Now for Fast Delivery of Your Neurodegenerative Disorder Therapeutics Market Report!
Which Geographic Locations Are Critical to the Growth of the Neurodegenerative Disorder Therapeutics Market?
North America was the largest region in the global neurodegenerative disorder therapeutics market in 2023. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the neurodegenerative disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The Neurodegenerative Disorder Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the neurodegenerative disorder therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Neurodegenerative Disorder Therapeutics Market Include
1. Neurodegenerative Disorder Therapeutics Market Executive Summary
2. Neurodegenerative Disorder Therapeutics Market Segments
3. Neurodegenerative Disorder Therapeutics Market Size And Template Market Growth Rate
4. Key Neurodegenerative Disorder Therapeutics Market Trends
5. Major Neurodegenerative Disorder Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market
26. Top Neurodegenerative Disorder Therapeutics Companies
27. Neurodegenerative Disorder Therapeutics Market Opportunities And Strategies
28. Neurodegenerative Disorder Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Interventional Neurology Devices And Equipment Global Market Report 2024
Neurosurgery Devices And Equipment Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
